Changes to CQC’s Attitude Towards Management of Controlled Drugs

The Care Quality Commission (CQC) has published its annual review of the management of controlled drugs in England.  The report looks at the performance of those managing controlled drugs in England under the Controlled Drugs (Supervision of Management and Use) Regulations 2013 and make recommendations for the future.

Recommendations

  1. Prescribers should ask patients about their existing prescriptions and
    current medicines when prescribing controlled drugs. Where possible,
    prescribers should also inform the patient’s GP to make them aware of
    treatment to minimise the risk of overprescribing that could lead to harm.
  2. Commissioners of health and care services should include the governance
    and reporting of concerns around controlled drugs as part of the
    commissioning and contracting arrangements so that these are not
    overlooked.
  3. Healthcare professionals should keep their personal identification badges
    and passwords secure and report any losses as soon as possible to
    enable organisations to take the necessary action.
  4. Health and care staff should consider regular monitoring and auditing
    arrangements for controlled drugs in the lower schedules, such as
    Schedules 4 and 5, to identify and take swift action on diversion.
This entry was posted in Healthcare. Bookmark the permalink.

Comments are closed.